THR-β agonist 4
Modify Date: 2024-01-15 22:31:08
THR-β agonist 4 structure
|
Common Name | THR-β agonist 4 | ||
|---|---|---|---|---|
| CAS Number | 2673409-25-9 | Molecular Weight | 510.26 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C16H11Cl2F2N5O6S | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of THR-β agonist 4THR-β agonist 4 is a potent agonist of THR-β. THR-β agonist 4 has the potential for the research of metabolic diseases such as obesity, hyperlipidemia, hypercholesterolemia, diabetes and other conditions such as steatosis and non-alcoholic steatohepatitis (NASH), atherosclerosis and other related conditions and diseases (extracted from patent WO2021143706A1, compound 72)[1]. |
| Name | THR-β agonist 4 |
|---|
| Description | THR-β agonist 4 is a potent agonist of THR-β. THR-β agonist 4 has the potential for the research of metabolic diseases such as obesity, hyperlipidemia, hypercholesterolemia, diabetes and other conditions such as steatosis and non-alcoholic steatohepatitis (NASH), atherosclerosis and other related conditions and diseases (extracted from patent WO2021143706A1, compound 72)[1]. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C16H11Cl2F2N5O6S |
|---|---|
| Molecular Weight | 510.26 |